全球口服固体製剂合约製造市场报告

预计到 2030 年，全球口服固体製剂合约製造市场的市场规模将从 2022 年的 329.7 亿美元达到近 615.7 亿美元，2023-2030 年研究期间复合年增长率为 8.12%。

推动口服固体製剂合约製造市场的主要因素包括病毒和慢性疾病的流行以及可治癒疾病的药品的增加。此外，药物的广泛使用等其他因素导致了对大规模生产创新疗法来治疗各种疾病的患者的广泛需求。随着大规模生产需求的增加，大型製药公司逐渐外包合约製造。因此，随着对创新药物的需求增加，对口服固体剂合约生产的需求也将增加。未来几年，经济繁荣和健康意识的提高预计也将对市场成长产生正面影响。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球口服固体製剂合约製造市场的每个细分市场进行了包容性评估。口服固体製剂合约製造业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲口服固体製剂合约製造市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。口服固体製剂合约製造市场的主要参与者包括 Catalent Inc、Lonza Group、Piramal Pharma Solutions、Aenova、Jubilant、Boehringer Ingelheim、AbbVie Contract Manufacturing、Patheon、Recipharm、Next Pharma AB、Siegfried AG、Corden Pharma。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：口服固体製剂合约製造 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 市场吸引力分析：按产品类型
  • 市场吸引力机制分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球口服固体製剂合约製造市场分析：依产品类型

• 概述：按产品类型
• 历史和预测数据
• 分析：依产品类型
• 平板电脑
• 胶囊
• 粉末
• 颗粒剂
• 其他（含片、软糖、锭剂等）

第 7 章：全球口服固体製剂合约製造市场分析：按机制

• 按机制概述
• 历史和预测数据
• 按机制分析
• 立即发布
• 延迟发布
• 控释

第 8 章：全球口服固体製剂合约製造市场销售分析：按最终用户分类

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 大型公司
• 中小型企业
• 其他（新创公司和仿製药公司）

第 9 章：全球口服固体製剂合约製造市场销售分析：按地理位置

• 区域展望销售分析
• 简介 销售分析
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 10 章：口服固体製剂合约製造公司的竞争格局

• 口服固体製剂合约製造市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 十大公司股票分析
• 市场集中度
• Catalent Inc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Lonza Group
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Piramal Pharma Solutions
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Aenova
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Jubilant
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boehringer Ingelheim
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AbbVie Contract Manufacturing
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Patheon
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Recipharm
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Next Pharma AB
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Siegfried AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Corden Pharma
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Oral Solid Dosage Contract Manufacturing Market is presumed to reach the market size of nearly USD 61.57 BN by 2030 from USD 32.97 BN in 2022 with a CAGR of 8.12% under the study period 2023 - 2030.

The major factors driving the oral solid dosage contract manufacturing market include the prevalence of viral and chronic diseases and increased pharmaceutical goods that can cure diseases. Moreover, additional factors like the widespread usage of pharmaceutical drugs have caused the extensive need for the large-scale production of innovative treatments for patients suffering from various ailments. Major pharmaceutical corporations are progressively outsourcing contract manufacturing as the need for large-scale production increases. As a result, as demand for innovative medicines rises, so will the need for oral solid dose contract manufacturing. In the years to come, higher economic prosperity and greater health awareness are also projected to positively impact market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oral solid dosage contract manufacturing. The growth and trends of oral solid dosage contract manufacturing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the oral solid dosage contract manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Tablets
• Capsules
• Powders
• Granules
• Others (Lozenges, Gummies, Pastilles, Etc.)

By Mechanism

• Immediate-Release
• Delayed-Release
• Controlled-Release

By End-User

• Large-Size Companies
• Medium- & Small-Size Companies
• Others (Startups & Generic Pharmaceutical Companies)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Oral Solid Dosage Contract Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the oral solid dosage contract manufacturing market include Catalent Inc, Lonza Group, Piramal Pharma Solutions, Aenova, Jubilant, Boehringer Ingelheim, AbbVie Contract Manufacturing, Patheon, Recipharm, Next Pharma AB, Siegfried AG, Corden Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ORAL SOLID DOSAGE CONTRACT MANUFACTURING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Mechanism
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET ANALYSIS BY PRODUCT TYPE

• 6.1 Overview by Product Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product Type
• 6.4 Tablets Historic and Forecast Sales by Regions
• 6.5 Capsules Historic and Forecast Sales by Regions
• 6.6 Powders Historic and Forecast Sales by Regions
• 6.7 Granules Historic and Forecast Sales by Regions
• 6.8 Others (Lozenges, Gummies, Pastilles, etc.) Historic and Forecast Sales by Regions

7 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET ANALYSIS BY MECHANISM

• 7.1 Overview by Mechanism
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Mechanism
• 7.4 Immediate-release Historic and Forecast Sales by Regions
• 7.5 Delayed-release Historic and Forecast Sales by Regions
• 7.6 Controlled-release Historic and Forecast Sales by Regions

8 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SALES ANALYSIS BY END-USER

• 8.1 Overview by End-user
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-user
• 8.4 Large-size Companies Historic and Forecast Sales by Regions
• 8.5 Medium- & Small-size Companies Historic and Forecast Sales by Regions
• 8.6 Others (Startups & Generic Pharmaceutical Companies) Historic and Forecast Sales by Regions

9 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ORAL SOLID DOSAGE CONTRACT MANUFACTURING COMPANIES

• 10.1. Oral Solid Dosage Contract Manufacturing Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF ORAL SOLID DOSAGE CONTRACT MANUFACTURING INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Catalent Inc
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Lonza Group
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Piramal Pharma Solutions
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Aenova
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Jubilant
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Boehringer Ingelheim
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. AbbVie Contract Manufacturing
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Patheon
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Recipharm
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Next Pharma AB
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments
• 11.13. Siegfried AG
  • 11.13.1. Company Overview
  • 11.13.2. Company Revenue
  • 11.13.3. Products
  • 11.13.4. Recent Developments
• 11.14. Corden Pharma
  • 11.14.1. Company Overview
  • 11.14.2. Company Revenue
  • 11.14.3. Products
  • 11.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product Type (USD MN)
• Tablets Market Sales by Geography (USD MN)
• Capsules Market Sales by Geography (USD MN)
• Powders Market Sales by Geography (USD MN)
• Granules Market Sales by Geography (USD MN)
• Others (Lozenges, Gummies, Pastilles, etc.) Market Sales by Geography (USD MN)
• Analysis Market by Mechanism (USD MN)
• Immediate-release Market Sales by Geography (USD MN)
• Delayed-release Market Sales by Geography (USD MN)
• Controlled-release Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Large-size Companies Market Sales by Geography (USD MN)
• Medium- & Small-size Companies Market Sales by Geography (USD MN)
• Others (Startups & Generic Pharmaceutical Companies) Market Sales by Geography (USD MN)
• Global Oral Solid Dosage Contract Manufacturing Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Oral Solid Dosage Contract Manufacturing Report
• Market Research Process
• Market Research Methodology
• Global Oral Solid Dosage Contract Manufacturing Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product Type
• Market Attractiveness Analysis by Mechanism
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product Type (USD MN)
• Tablets Market Sales by Geography (USD MN)
• Capsules Market Sales by Geography (USD MN)
• Powders Market Sales by Geography (USD MN)
• Granules Market Sales by Geography (USD MN)
• Others (Lozenges, Gummies, Pastilles, etc.) Market Sales by Geography (USD MN)
• Global Market Analysis by Mechanism (USD MN)
• Immediate-release Market Sales by Geography (USD MN)
• Delayed-release Market Sales by Geography (USD MN)
• Controlled-release Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Large-size Companies Market Sales by Geography (USD MN)
• Medium- & Small-size Companies Market Sales by Geography (USD MN)
• Others (Startups & Generic Pharmaceutical Companies) Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.